AR
CORT icon

Advisory Research’s Corcept Therapeutics CORT Stock Holding History

Advisory Research’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,087
Closed -$643K – 373
2022
Q3 		$643K Buy
25,087
+150
+0.6% +$4.01K 0.06% 207
2022
Q2 		$593K Buy
+24,937
New +$543K 0.06% 207
2018
Q1 		– Sell
-64,423
Closed -$1.16M – 382
2017
Q4 		$1.16M Buy
64,423
+13,398
+26% +$243K 0.02% 264
2017
Q3 		$985K Sell
51,025
-56,411
-53% -$841K 0.02% 312
2017
Q2 		$1.27M Sell
107,436
-52,783
-33% -$574K 0.02% 286
2017
Q1 		$1.76M Buy
+160,219
New +$1.41M 0.03% 263

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return